EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study

Fabrizio Cavalca, Roberto Latagliata, Novella Pugliese, Giuseppe Alberto Palumbo, Nicola Polverelli, Pellegrino Musto, Giulia Benevolo, Filippo Branzanti, Ambra Di Veroli, Eugenia Accorsi Buttini, Alessia Ripamonti, Ivan Civettini und 5 weitere

Annals of Hematology · 2026

DOI: 10.1007/s00277-026-06763-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, 2026. Verfasst von Fabrizio Cavalca und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Division and Bone Marrow Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy. fabrizio.cavalca@irccs-sangerardo.it. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Neutrophils, Venous Thrombosis, Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by splenomegaly, symptoms, cytopenias, and chronic inflammation. PMF has two stages: pre-fibrotic (prePMF) and overt PMF. PrePMF and essential thrombocythemia share a similar high thrombotic risk, but few studies have examined thrombosis risk factors in prePMF. The neutrophil-to-lymphocyte ratio (NLR), reflecting the imbalance between systemic inflammation and immunity, has emerged as a prognostic biomarker in various diseases. We investigated the predictive value of NLR for thrombotic risk in a multicenter cohort of 225 prePMF patients enrolled in the retro-prospective observational INFLA-ME (INFLAmmation in MyeloproliferativE disease) cooperative study. After a median follow-up of 5.9 years, 37 thrombotic events occurred in 31 patients (2.5 events/100 patients/year; 18 arterial, 19 venous). Multivariate analysis linked venous thrombosis risk to prior venous events (HR 4.46, p = 0.001) and NLR ≥ 6 (HR 3.82, p = 0.008). The patients with NLR ≥ 6 showed a shorter venous thrombosis-free survival (p = 0.003). NLR value had no significant association with total and arterial thrombotic events. In conclusion, NLR is an inexpensive and accessible prognostic biomarker of venous thrombosis in prePMF. The integration of NLR into conventional risk scores may allow for better identification of pre-PMF patients requiring cytoreduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary MyelofibrosisNeutrophilsVenous ThrombosisLymphocytesHumansFemaleMaleAgedMiddle AgedProspective StudiesFollow-Up StudiesAged, 80 and overAdultPrognosisPredictive Value of TestsRisk Factors

Stichwörter der Autor:innen

InflammationMyeloproliferative neoplasmNLRNeutrophil-to-lymphocyte ratioPrimary prefibrotic myelofibrosisThrombosis

Autor:innen und Institutionen

  • Hematology Division and Bone Marrow Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy. fabrizio.cavalca@irccs-sangerardo.it.
  • Hematology Unit, Santa Rosa Hospital, Viterbo, 01100, Italy.
  • Department of Clinical Medicine and Surgery, Hematology Section, University of Naples "Federico II", Naples, 80131, Italy.
  • Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", University of Catania, Catania, 95123, Italy.
  • Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology, Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, 2…
  • Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy.

Zitieren

APA

Cavalca, F., Latagliata, R., Pugliese, N., Palumbo, G. A., Polverelli, N., Musto, P., Benevolo, G., Branzanti, F., Di Veroli, A., Buttini, E. A., Ripamonti, A., Civettini, I., Montelisciani, L., Antolini, L., Gambacorti-Passerini, C., Palandri, F., & Elli, E. M. (2026). Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study. Annals of Hematology. https://doi.org/10.1007/s00277-026-06763-1

Vancouver

Cavalca F, Latagliata R, Pugliese N, Palumbo GA, Polverelli N, Musto P, et al. Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study. Annals of Hematology. 2026. doi:10.1007/s00277-026-06763-1

BibTeX
@article{Cavalca2026,
  author = {Cavalca, Fabrizio and Latagliata, Roberto and Pugliese, Novella and Palumbo, Giuseppe Alberto and Polverelli, Nicola and Musto, Pellegrino and Benevolo, Giulia and Branzanti, Filippo and Di Veroli, Ambra and Buttini, Eugenia Accorsi and Ripamonti, Alessia and Civettini, Ivan and Montelisciani, Laura and Antolini, Laura and Gambacorti-Passerini, Carlo and Palandri, Francesca and Elli, Elena Maria},
  title = {Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-06763-1}
}
Kostenlos starten →